Ausgabe 8/2022
Inhalt (8 Artikel)
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Arnaldo Figueiredo, Luís Costa, Maria Joaquina Maurício, Luís Figueira, Rodrigo Ramos, Carlos Martins-da-Silva
Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
Daniel Tobias Michaeli, Julia Caroline Michaeli, Tobias Boch, Thomas Michaeli
Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet
Mohamed Badawi, Xin Chen, Patrick Marroum, Ahmed A. Suleiman, Sven Mensing, Anette Koenigsdorfer, Julia Teresa Schiele, Tammy Palenski, Divya Samineni, David Hoffman, Rajeev Menon, Ahmed Hamed Salem
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study
Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Basem Alraddadi, Alaa Alali, James Jarrett, Sam Kozma, Camille Harfouche, Tariq Al Musawi
Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer
Chao Li, Janet K. Horton, Mark Sale, Laura Curd, Vineet Goti, Wenli Tao, Andrew Beelen
Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19
Noa Berar Yanay, Ido Bogner, Khader Saker, Elias Tannous
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports
Alberto Quinzii, Camilla Zecchetto, Simona Casalino, Marina Gaule, Camilla Pesoni, Valeria Merz, Serena Contarelli, Silvia Pietrobono, Karim A. Benhadji, Davide Melisi